Menopausal hormone therapy: what TikTok gets right and wrong

What did @drmauriciogonzalez actually say?

Honestly, not much, at least not in this clip. The transcript captured is essentially a false start: "I'm not sure if I'm going to be able to do this. I'm going to have a little bit of a rest. You know what I mean? Dr. Maum, in for now." That is the entirety of the spoken content available for review. Whatever the video's caption promises about estradiol, progesterone, and menopausal hormone therapy sourced from UpToDate 2026, the transcript does not deliver it. This fact-check is therefore working with a significant gap between the metadata and what was actually said on camera.

The caption references legitimate clinical territory: menopausal hormone therapy (MHT) is a well-studied, guideline-supported treatment area. The hashtags suggest estradiol and progesterone are the focal hormones. But a caption is not a claim. We can only fact-check what was spoken.

Does the science back this up?

There is nothing substantive in the transcript to evaluate against the literature. That said, the framing around this video deserves some scrutiny on its own terms. The UpToDate citation listed in the caption is legitimate, and MHT for menopausal symptoms is well-supported by evidence, including the landmark WHI reanalysis and subsequent data from the Menopause Society.

Estradiol, particularly transdermal formulations, is associated with reduced vasomotor symptoms in the majority of women and carries a more favorable cardiovascular and thrombotic risk profile than oral conjugated equine estrogens, according to Canonico et al. (2010, Circulation) and Scarabin et al. (2003, Lancet). Micronized progesterone, when used alongside estradiol, appears to carry lower breast cancer risk signals than synthetic progestins, per the E3N cohort study (Fournier et al., 2008, Breast Cancer Research and Treatment). These are not fringe positions. They are reflected in current North American Menopause Society guidance. If that is where Dr. Gonzalez was heading, the science would largely have supported him.

What did they get wrong (or right)?

There is no clinical claim in this transcript to mark right or wrong. What we can flag is a structural problem: the video's category tag is "TRT" (testosterone replacement therapy for hypogonadism), but the content, based on the caption, appears to be about MHT for menopause. That is a meaningful mismatch. Estradiol and progesterone for menopause is not TRT. Testosterone can be used adjunctively in menopause management for libido, per the Global Consensus Statement on Testosterone Use in Women (Davis et al., 2019, Journal of Clinical Endocrinology and Metabolism), but that is a different conversation and not referenced in the caption.

The citation of "UpToDate, 2026" is also worth a raised eyebrow. UpToDate is a continuously updated clinical resource, not a published study with a fixed year. Citing it as a static 2026 source is a minor but real credibility issue. It implies a rigor that the format does not quite support.

What should you actually know?

If you came to this video looking for real information on hormone therapy for menopause, here is what the actual evidence says. Menopausal hormone therapy is effective for hot flashes, night sweats, and genitourinary symptoms. Transdermal estradiol is generally preferred over oral forms for women with cardiovascular or clotting risk factors. Micronized progesterone is the preferred progestogen for women with a uterus, based on current evidence and professional society guidance from the Menopause Society and ACOG.

The old fear framework from the original 2002 WHI publication has been substantially revised. Age and timing of initiation matter enormously. Women who start MHT within 10 years of menopause or before age 60 see a more favorable benefit-risk ratio, per Manson et al. (2013, JAMA Internal Medicine). If you are navigating menopause decisions, that context matters more than a TikTok caption, regardless of the credentials attached to it.